Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +9 vs. Q1 2022
- Shares held
- 3.97M
- −190.1K (−4.6%) vs. Q1 2022
- Total value
- $11.0M
- −$2.97M (−21.3%) vs. Q1 2022
- New holders
- 11
- 6 more added
- Sold out
- 2
- 17 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,427,902 | $3.94M | 0.00% | +6,803+0.5% | Added |
| BlackRock Inc. | 473,733 | $1.31M | 0.00% | −777−0.2% | Reduced |
| Geode Capital Management, LLC | 275,909 | $761.0K | 0.00% | −7,576−2.7% | Reduced |
| Abner Herrman & Brock LLC | 265,000 | $731.0K | 0.13% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 253,432 | $698.0K | 0.29% | −50,729−16.7% | Reduced |
| Raymond James & Associates | 187,403 | $517.0K | 0.00% | −3,000−1.6% | Reduced |
| JPMorgan Chase & Co | 187,070 | $516.0K | 0.00% | −59,132−24.0% | Reduced |
| Millennium Management LLC | 109,996 | $304.0K | 0.00% | −31,257−22.1% | Reduced |
| Weaver Consulting Group | 104,653 | $289.0K | 0.16% | −25,347−19.5% | Reduced |
| State Street Corp | 96,060 | $265.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 93,000 | $257.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 55,916 | $154.0K | 0.00% | 00.0% | Unchanged |
| Jmac Enterprises LLC | 45,430 | $125.0K | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 40,982 | $113.0K | 0.00% | −8,124−16.5% | Reduced |
| IFP Advisors, Inc | 19,850 | $104.0K | 0.00% | 00.0% | Unchanged |
| Liberty Wealth Management LLC | 30,000 | $82.0K | 0.03% | +30,000 | New |
| Boothbay Fund Management, LLC | 27,868 | $77.0K | 0.00% | −1,318−4.5% | Reduced |
| Citadel Advisors LLC | 25,685 | $70.0K | 0.00% | +1,566+6.5% | Added |
| S.C. Financial Services, Inc. | 25,471 | $70.0K | 0.11% | +10,186+66.6% | Added |
| Group One Trading, L.P. | 24,134 | $67.0K | 0.00% | −24,963−50.8% | Reduced |
| Virtu Financial LLC | 20,702 | $57.0K | 0.00% | +20,702 | New |
| Wells Fargo & Company | 17,897 | $50.0K | 0.00% | +1,672+10.3% | Added |
| Renaissance Technologies LLC | 17,100 | $47.0K | 0.00% | +17,100 | New |
| HighPoint Advisor Group LLC | 17,033 | $45.0K | 0.00% | +17,033 | New |
| Susquehanna International Group, LLP | 15,323 | $42.0K | 0.00% | −79,277−83.8% | Reduced |
| Jane Street Group, LLC | 12,085 | $33.0K | 0.00% | +12,085 | New |
| Bank of New York Mellon Corp | 11,528 | $32.0K | 0.00% | −722−5.9% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 11,748 | $32.0K | 0.00% | −283−2.4% | Reduced |
| Charles Schwab Investment Management Inc | 11,287 | $32.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10,839 | $31.0K | 0.00% | 00.0% | Unchanged |
| Aptus Capital Advisors, LLC | 10,210 | $28.0K | 0.00% | −2,290−18.3% | Reduced |
| UBS Group AG | 7,795 | $22.0K | 0.00% | +89+1.2% | Added |
| Bank of America Corp | 7,611 | $21.0K | 0.00% | +389+5.4% | Added |
| Steward Partners Investment Advisory, LLC | 6,700 | $18.0K | 0.00% | −1,000−13.0% | Reduced |
| Tower Research Capital LLC (TRC) | 5,544 | $15.0K | 0.00% | +5,544 | New |
| Bangor Savings Bank | 4,000 | $11.0K | 0.00% | +4,000 | New |
| Institutional & Family Asset Management, LLC | 3,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 2,634 | $7.00K | 0.00% | +2,634 | New |
| Royal Bank of Canada | 1,533 | $4.00K | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 1,000 | $3.00K | 0.00% | +1,000 | New |
| BNP Paribas Arbitrage, SA | 364 | $1.00K | 0.00% | −117−24.3% | Reduced |
| First Manhattan Co | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 200 | $0 | 0.00% | −2,178−91.6% | Reduced |
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 35 | $0 | 0.00% | +35 | New |
| CoreCap Advisors, LLC | 133 | $0 | 0.00% | +133 | New |
| CFO4Life Group, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |